Caladrius Biosciences, Inc. Appoints Anne Whitaker to Board of Directors
November 02, 2020 at 07:00 pm IST
Caladrius Biosciences, Inc. announced the appointment of Anne Whitaker to its Board of Directors. Ms. Whitaker is a seasoned healthcare executive bringing to Caladrius 28 years of experience in the life science industry, including senior leadership roles with large pharmaceutical, biotech and specialty pharma companies, and with a proven track record of building and leading high performance teams to successfully commercialize pharmaceuticals, consumer products and medical devices. Ms. Whitaker is currently the CEO of Aerami Therapeutics.